• Yuzhou Chen, Luxin Zong, Qunde Zhao, and Chuanxin Liu.
• Jining Medical University, Jining, China.
• Medicine (Baltimore). 2024 Oct 18; 103 (42): e40045e40045.

AbstractAlcohol use disorder (AUD) has become a global public health challenge, with the social and economic costs of alcohol abuse escalating, drawing widespread attention from healthcare professionals and the public worldwide. Particularly in recent years, the COVID-19 pandemic and associated lockdown measures have led to a significant increase in global alcohol consumption, further exacerbating the risk of AUD and sparking in-depth discussions on its prevention and treatment methods. Given that the current mainstay of AUD treatment relies on pharmacotherapy, the aim of this article is to review the progress of existing drug research for the treatment of AUD, and at the same time to focus on drug classes that have not yet been applied to the clinic, but have been shown in recent studies to be potentially exploitable for the treatment of AUD, in order to provide new ideas and directions for future drug research and development efforts.Copyright © 2024 the Author(s). Published by Wolters Kluwer Health, Inc.

7 keywords...

hide…